Literature DB >> 15254626

Preparation of enantiopure biimidazoline ligands and their use in asymmetric catalysis.

Nicola A Boland1, Mike Casey, Stephen J Hynes, Jonathan W Matthews, Helge Muller-Bunz, Philippa Wilkes.   

Abstract

A convenient new method for the preparation of 2,2'-biimidazolines is reported. Amino alcohols were reacted with dimethyl oxalate, and the product hydroxy amides converted into chloroamides by reaction with thionyl chloride. Treatment with PCl5, followed by diamines (ethanediamine, propane-1,3-diamine, 2,2-dimethylpropane-1,3-diamine) furnished a series of enantiopure tricyclic biimidazolines. Complexes of two of the ligands with PdCl2 were prepared and their X-ray crystal structures were determined. The biimidazolines were tested as ligands for asymmetric Pd-catalysed allylations. Moderate enantioselectivity (up to 80% ee) was found for the reaction of dimethyl malonate with diphenylallyl acetate, with the 5,7,5 fused tricyclic systems outperforming the 5,6,5 analogues. The corresponding reaction of pentenyl acetate gave lower enantioselectivity (44-57% ee), and proved very sensitive to the donor strength of the ligands, the stronger donors giving lower yields. The results provide a further demonstration of the value of the 'tunability' of imidazoline ligands.

Entities:  

Year:  2004        PMID: 15254626     DOI: 10.1039/b407743c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Azomethine ylide mediated inversion of configuration of quaternary imidazoline carbon: converting trans- to its cis- imidazolines.

Authors:  Ke Qu; Jason S Fisk; Jetze J Tepe
Journal:  Tetrahedron Lett       Date:  2011-09-21       Impact factor: 2.415

2.  Ni/Photoredox-Catalyzed Enantioselective Cross-Electrophile Coupling of Styrene Oxides with Aryl Iodides.

Authors:  Sii Hong Lau; Meredith A Borden; Talia J Steiman; Lucy S Wang; Marvin Parasram; Abigail G Doyle
Journal:  J Am Chem Soc       Date:  2021-09-20       Impact factor: 15.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.